Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study
Journal of Diabetes Investigation · 2026
DOI: 10.1111/jdi.70205 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Dong-Hoe Koo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Prediabetic State, Blood Glucose, Diabetes Mellitus. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Hyperglycemia or diabetes mellitus (DM) is a well‐known risk factor for pancreatic cancer, but it is uncertain whether well‐controlled glycemic status can affect the pancreatic cancer incidence rate.
Methods
This study used 2,993,519 individuals who underwent four consecutive national annual health screenings between 2009 and 2013. The study participants were divided into three groups: nondiabetes mellitus (non‐DM), new‐onset DM, and known DM. Each group was further subcategorized based on the fasting blood glucose (FBG) levels and use of antidiabetic medication: well‐controlled (126).
Results
During a median follow‐up of 6.3 years, the incidence rate of pancreatic cancer in the non‐DM group significantly increased in the moderately controlled group compared with that in the well‐controlled group, regardless of whether the FBG level was recently or initially elevated. However, no dose–response relationship was observed between glucose control status and pancreatic cancer incidence, although the incidence of pancreatic cancer in the new DM and known DM groups was generally higher than that in the non‐DM group.
Conclusion
The pancreatic cancer incidence rate in the non‐DM group significantly increased in the poorly controlled group. These findings suggest that in populations without DM, maintaining optimal glucose control may be associated with a lower risk of developing pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Zitieren
APA
Koo, D. H., Jung, J. H., Han, K., & Park, C. Y. (2026). Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70205
Vancouver
Koo DH, Jung JH, Han K, Park CY. Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70205
BibTeX
@article{Koo2026,
author = {Koo, Dong-Hoe and Jung, Jin-Hyung and Han, Kyungdo and Park, Cheol-Young},
title = {Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study},
journal = {Journal of Diabetes Investigation},
year = {2026},
doi = {10.1111/jdi.70205}
}
EUVIMED